Applications of SARS-CoV-2 serological testing: impact of test performance, sample matrices, and patient characteristics

CYJ Fung, M Scott, J Lerner-Ellis… - Critical reviews in clinical …, 2024 - Taylor & Francis
Laboratory testing has been a key tool in managing the SARS-CoV-2 global pandemic.
While rapid antigen and PCR testing has proven useful for diagnosing acute SARS-CoV-2 …

Inactivated COVID-19 vaccines: potential concerns of antibody-dependent enhancement and original antigenic sin

AKC Kan, PH Li - Immunology Letters, 2023 - Elsevier
Inactivated vaccine is one of the platforms employed in COVID-19 vaccines. Inactivated
vaccines have been associated with concerns of antibody-dependent enhancement (ADE) …

Induction of SARS-CoV-2 neutralizing antibodies by CoronaVac and BNT162b2 vaccines in naïve and previously infected individuals

NA Muena, T García-Salum, C Pardo-Roa… - …, 2022 - thelancet.com
Background A major challenge of the SARS-CoV-2 pandemic is to better define" protective
thresholds" to guide the global response. We aimed to characterize the longitudinal …

Quantitative analysis of anti-N and anti-S antibody titers of SARS-CoV-2 infection after the third dose of COVID-19 vaccination

N Lee, S Jeong, SK Lee, EJ Cho, J Hyun, MJ Park… - Vaccines, 2022 - mdpi.com
We quantitatively analyzed SARS-CoV-2 antibody levels in patients after two doses of the
ChAdOx1 nCoV-19 vaccine and the third BNT162b2 booster. We obtained 255 serum …

Immunoglobulins response of COVID-19 patients, COVID-19 vaccine recipients, and random individuals

M Al-Tamimi, AA Tarifi, A Qaqish, MM Abbas… - Plos one, 2023 - journals.plos.org
Background The development of specific immunoglobulins to COVID-19 after natural
infection or vaccination has been proposed. The efficacy and dynamics of this response are …

An agent-based transmission model of COVID-19 for re-opening policy design

A Rodríguez, E Cuevas, D Zaldivar… - Computers in Biology …, 2022 - Elsevier
The global pandemic caused by the coronavirus (COVID-19) disease has collapsed the
worldwide economy. Elements such as non-obligatory vaccination, new strain variants and …

SARS‐CoV‐2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February …

EW Kagucia, AK Ziraba, J Nyagwange… - Influenza and other …, 2023 - Wiley Online Library
Background We sought to estimate SARS‐CoV‐2 antibody seroprevalence within
representative samples of the Kenyan population during the third year of the COVID‐19 …

Correlation between anti-S IgG and neutralizing antibody titers against three live SARS-CoV-2 variants in BNT162b2 vaccine recipients

Y Higashimoto, K Kozawa, H Miura… - Human vaccines & …, 2022 - Taylor & Francis
We analyzed serially collected serum samples from healthy adults who underwent
BNT162b2 vaccination to elucidate the association between spike (S)-IgG antibody titers …

[HTML][HTML] Kinetics of SARS-CoV-2 IgM and IgG antibodies 3 months after COVID-19 onset in Moroccan patients

N Assaid, S Arich, H Charoute, K Akarid… - The American Journal …, 2023 - ncbi.nlm.nih.gov
Coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) poses serious global public health problems. Characterization of the …

Longevity and Neutralizing Capacity of IgG Antibodies against SARS-CoV-2 Generated by the Application of BNT162b2, AZD1222, Convidecia, Sputnik V, and …

L Fernandes-Matano, AG Salas-Lais… - Microbiology …, 2023 - Am Soc Microbiol
The WHO has approved the use of several vaccines during the COVID-19 pandemic;
experience over the last 2 years has indicated that dose demand can only be covered using …